Page 1 of 2
Case 1:20-cr-00330-PAE Document 409 _ Filed 11/03/21 Pagelof2
UNITED STATES DISTRICT COURT irae |
SOUTHERN DISTRICT OF NEW YORK secre ies
DOC #:
DATE FILED:_11/3/21
United States of America,
_y_
20-CR-330 (AJN)
Ghislaine Maxwell,
ORDER
Defendant.
ALISON J. NATHAN, District Judge:
The Court is in receipt of the parties’ joint letter in response to this Court’s order dated
October 31, 2021. Dkt. No. 406. The Court will hold a hearing on November 10, 2021 at 9:00
a.m. on the Defendant’s motion under Federal Rule of Evidence 412, Dkt. No. 378, the
Defendant’s motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other
outstanding issues that overlap with these two motions as discussed at the November 1, 2021
conference. The proceeding will take place in Courtroom 110 of the United States District Court
for the Southern District of New York, Thurgood Marshall U.S. Courthouse at 40 Foley Square,
New York, New York. The Court will provide information on public access (for the portion of
the Daubert hearing that does not overlap with the Rule 412 issues) as soon as it is available.
Otherwise, the Court will order the following briefing schedule if the Government seeks
to exclude any of the Defendant’s anticipated witness testimony as disclosed in her November 1,
2021 notice. See Dkt. No. 406:
e Government brief to be filed on ECF: November 8, 2021
e Defense response brief to be filed on ECF: November 11, 2021
DOJ-OGR-00006063